Lnc-DC promotes estrogen independent growth and tamoxifen resistance in breast cancer
Abstract Selective estrogen receptor modulators (SERMs) such as tamoxifen have proven to be effective in the treatment of estrogen receptor (ER) positive breast cancer. However, a major obstacle for such endocrine therapy is estrogen independent growth, leading to resistance, and the underlying mech...
Saved in:
| Main Authors: | Wan-Xin Peng, Pratirodh Koirala, Huaixiang Zhou, Jiahong Jiang, Ziqiang Zhang, Liu Yang, Yin-Yuan Mo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2021-10-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-021-04288-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Lnc-DC promotes estrogen independent growth and tamoxifen resistance in breast cancer
by: Wan-Xin Peng, et al.
Published: (2025-01-01) -
PARP14-mediated glycolysis enhances Tamoxifen resistance in estrogen receptor + breast cancer cells
by: Wenju Mo, et al.
Published: (2025-06-01) -
A Role for Estrogen Receptor Phosphorylation in the Resistance to Tamoxifen
by: Renée de Leeuw, et al.
Published: (2011-01-01) -
Tamoxifen Molecular Targets Different From Estrogen Receptors
by: T. A. Bogush, et al.
Published: (2020-05-01) -
Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.
by: Takayuki Watanabe, et al.
Published: (2021-01-01)